91 related articles for article (PubMed ID: 7985463)
1. Effects of controlled ovarian hyperstimulation on corpus luteum and endometrial function.
Cittadini E; Palermo R; Napoli P
Acta Eur Fertil; 1993; 24(5):195-9. PubMed ID: 7985463
[No Abstract] [Full Text] [Related]
2. Reproductive biology and IVF: ovarian stimulation and endometrial receptivity.
Devroey P; Bourgain C; Macklon NS; Fauser BC
Trends Endocrinol Metab; 2004 Mar; 15(2):84-90. PubMed ID: 15036255
[TBL] [Abstract][Full Text] [Related]
3. [Functional insufficiency of corpus luteum].
Cohen J
Contracept Fertil Sex (Paris); 1976; 4(3):193-5, 198-202. PubMed ID: 1261730
[No Abstract] [Full Text] [Related]
4. Follicular recruitment is reduced in minimal stimulation for controlled ovarian hyperstimulation using purified human menopausal gonadotropin compared with follicle-stimulating hormone.
Park JK; Clark R; Session DR
Fertil Steril; 2009 Apr; 91(4 Suppl):1434-6. PubMed ID: 18701097
[TBL] [Abstract][Full Text] [Related]
5. Appropriate methods to monitor controlled ovarian hyperstimulation?
Cebesoy FB
Fertil Steril; 2008 Apr; 89(4):1025; author reply 1025-6. PubMed ID: 18325501
[No Abstract] [Full Text] [Related]
6. Is controlled ovarian stimulation associated with adverse endometrial effects?
Birkenfeld A
Ann N Y Acad Sci; 1994 Sep; 734():193-7. PubMed ID: 7978917
[No Abstract] [Full Text] [Related]
7. Ovulation induction for luteal phase defects and luteal phase defects after ovulation induction.
Li TC; Warren MA
Baillieres Clin Obstet Gynaecol; 1993 Jun; 7(2):389-419. PubMed ID: 8358897
[No Abstract] [Full Text] [Related]
8. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists.
Saadat P; Boostanfar R; Slater CC; Tourgeman DE; Stanczyk FZ; Paulson RJ
Fertil Steril; 2004 Jul; 82(1):167-71. PubMed ID: 15237007
[TBL] [Abstract][Full Text] [Related]
9. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity.
Orvieto R; Meltzer S; Rabinson J; Zohav E; Anteby EY; Nahum R
Fertil Steril; 2008 Oct; 90(4):1294-6. PubMed ID: 18178197
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of clomiphene action in woman].
Escudero Fernández M; González-Conde CS; Vidart Aragón JA
Acta Ginecol (Madr); 1973 Apr; 24(4):279-90. PubMed ID: 4802831
[No Abstract] [Full Text] [Related]
11. Ovulation induction.
March CM
J Reprod Med; 1993 May; 38(5):335-46. PubMed ID: 8320669
[TBL] [Abstract][Full Text] [Related]
12. Effects of gonadotropin-releasing hormone agonists and antagonists on luteal function.
DiLuigi AJ; Nulsen JC
Curr Opin Obstet Gynecol; 2007 Jun; 19(3):258-65. PubMed ID: 17495643
[TBL] [Abstract][Full Text] [Related]
13. [Pulsatile gonadotropin releasing hormone treatment following previous ovarian hyperstimulation].
Koloszár S; Bártfai G
Orv Hetil; 1993 Jul; 134(28):1521-3. PubMed ID: 8341530
[TBL] [Abstract][Full Text] [Related]
14. [Onset and maintenance of the luteal phase with GnRH agonists or hCG in cycles under GnRH antagonists].
Olivennes F
J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S24-6. PubMed ID: 15643682
[TBL] [Abstract][Full Text] [Related]
15. Addition of human chorionic gonadotropin to clomiphene citrate ovulation induction therapy does not improve pregnancy outcomes and luteal function.
Yilmaz B; Kelekci S; Savan K; Oral H; Mollamahmutoglu L
Fertil Steril; 2006 Mar; 85(3):783-6. PubMed ID: 16500364
[TBL] [Abstract][Full Text] [Related]
16. Endometrial estrogen and progesterone receptors in cycles treated for infertility.
Bourgain C; Smitz J; Vandesteen N; Klöppel G; Devroey P; van Steirteghem AC
Prog Histochem Cytochem; 1992; 26(1-4):132-9. PubMed ID: 1484956
[No Abstract] [Full Text] [Related]
17. Use of GnRH analogues in ovulation induction for in vitro fertilization: benefit of a short administration regimen.
Barriere P; Lopes P; Boiffard JP; Pousset C; Quentin M; Sagot P; L'Hermite A; Lerat MF; Charbonnel B
J In Vitro Fert Embryo Transf; 1987 Feb; 4(1):64-5. PubMed ID: 3108427
[No Abstract] [Full Text] [Related]
18. GnRH antagonists in poor responders.
Kolibianakis E; Albano C; Zikopoulos K; Kahn JA; Van Steirteghem A; Devroey P
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1216-7. PubMed ID: 15548159
[No Abstract] [Full Text] [Related]
19. [Factors affecting the results of in vitro fertilization--III. The effect of the height and properties of the endometrium in the ultrasound image on the probability of implantation].
Mardesic T; Müller P; Zetová L; Miková M; Stroufová A
Ceska Gynekol; 1995 Feb; 60(1):3-7. PubMed ID: 7719589
[TBL] [Abstract][Full Text] [Related]
20. [Ovarian hyperstimulation syndrome. A complication of gonadotropin therapy].
Høie KE; Holst N; Forsdahl F; Ellingsen L
Tidsskr Nor Laegeforen; 1988 Jan; 108(1):15-6. PubMed ID: 3127928
[No Abstract] [Full Text] [Related]
[Next] [New Search]
